Ionis Pharmaceuticals Inc’s recent filing unveils that its Director Hayden Michael R acquired Company’s shares for reported $0.18 million on Dec 23 ’24. In the deal valued at $36.22 per share,5,000 shares were bought. As a result of this transaction, Hayden Michael R now holds 35,219 shares worth roughly $1.15 million.
Then, Swayze Eric sold 1,194 shares, generating $45,278 in total proceeds. Upon selling the shares at $37.92, the EVP Research now owns 33,713 shares.
Before that, Monia Brett P sold 6,630 shares. Ionis Pharmaceuticals Inc shares valued at $252,294 were divested by the Chief Executive Officer at a price of $38.05 per share. As a result of the transaction, Monia Brett P now holds 167,393 shares, worth roughly $5.47 million.
BMO Capital Markets downgraded its Ionis Pharmaceuticals Inc [IONS] rating to a Market perform from a an Outperform in a research note published on August 02, 2024; the price target was decreased to $60 from $67. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in late July from “a Market perform” to “an Outperform”. Bernstein revised its rating on June 14, 2024. It rated IONS as “a Mkt perform” which previously was an “an Underperform”.
Price Performance Review of IONS
On Tuesday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock fall -6.44% to $32.69. Over the last five days, the stock has lost -4.13%. Ionis Pharmaceuticals Inc shares have fallen nearly -6.49% since the year began. Nevertheless, the stocks have fallen -38.95% over the past one year. While a 52-week high of $53.17 was reached on 01/02/25, a 52-week low of $32.80 was recorded on 01/14/25. SMA at 50 days reached $36.29, while 200 days put it at $41.35.
Levels Of Support And Resistance For IONS Stock
The 24-hour chart illustrates a support level at 31.74, which if violated will result in even more drops to 30.80. On the upside, there is a resistance level at 34.50. A further resistance level may holdings at 36.32. The Relative Strength Index (RSI) on the 14-day chart is 36.31, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.20, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.16%. Stochastics %K at 20.47% indicates the stock is a holding.
How much short interest is there in Ionis Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ionis Pharmaceuticals Inc stocks on 2024-12-31, growing by 0.45 million shares to a total of 10.9 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 10.45 million shares. There was a rise of 4.16%, which implies that there is a positive sentiment for the stock.
